邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

药物诱发的自身免疫性及肿瘤性皮肤病

田晓寅,  左亚刚,  刘跃华,  孙秋宁

downloadPDF
文章导航 > 协和医学杂志  > 2012 >  3(4): 466-470
田晓寅, 左亚刚, 刘跃华, 孙秋宁. 药物诱发的自身免疫性及肿瘤性皮肤病[J]. 协和医学杂志, 2012, 3(4): 466-470. doi: 10.3969/j.issn.1674-9081.2012.04.023
引用本文: 田晓寅, 左亚刚, 刘跃华, 孙秋宁. 药物诱发的自身免疫性及肿瘤性皮肤病[J]. 协和医学杂志, 2012, 3(4): 466-470. doi: 10.3969/j.issn.1674-9081.2012.04.023
shu

药物诱发的自身免疫性及肿瘤性皮肤病

doi: 10.3969/j.issn.1674-9081.2012.04.023

  • 中国医学科学院 北京协和医学院 北京协和医院皮肤科, 北京 100730

详细信息
    通讯作者:

    左亚刚 电话:010-69156393, E-mail:zuoyagang@263.net

    孙秋宁 电话:010-69151544, E-mail:sunqnzhy@yahoo.com

  • 中图分类号: R758.25

    摘要
    • HTML全文
    • 参考文献(37)
  • [1] Hoffman BJ. Sensitivity of sulfadiazine resembling acute disseminated lupus erythematosus[J]. Arch Dermatol Syph, 1945, 51:190-192. doi:  10.1001/archderm.1945.01510210032007
    [2] Marzano AV, Vezzoli P, Crosti C. Drug-induced lupus:an update on its dermatologic aspects[J]. Lupus, 2009, 18:935-940. doi:  10.1177/0961203309106176
    [3] Marzano AV, Lazzari R, Polloni I, et al. Drug-induced subacute cutaneous lupus erythematosus:evidence for differences from its idiopathic counterpart[J]. Br J Dermatol, 2011, 165:335-341. doi:  10.1111/j.1365-2133.2011.10397.x
    [4] Peroni A, Zini A, Braga V, et al. Drug-induced morphea:report of a case induced by balicatib and review of the literature[J]. J Am Acad Dermatol, 2008, 59:125-129. doi:  10.1016/j.jaad.2008.03.009
    [5] Haustein UF, Haupt B. Drug-induced scleroderma and sclerodermiform conditions[J]. Clin Dermatol, 1998, 16:353-366. doi:  10.1016/S0738-081X(98)00006-6
    [6] Rünger TM, Adami S, Benhamou CL, et al. Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib[J]. J Am Acad Dermatol, 2012, 66:89-96. doi:  10.1016/j.jaad.2010.11.033
    [7] Maehana T, Mizuno T, Muto M, et al. Scleroderma-like skin sclerosis induced by docetaxel chemotherapy for hormone refractory prostate cancer:a case report[J]. Nihon Hinyokika Gakkai Zasshi, 2010, 101:726-729. http://europepmc.org/abstract/MED/20954379
    [8] Itoh M, Yanaba K, Kobayashi T, et al. Taxane-induced scleroderma[J]. Br J Dermatol, 2007, 156:363-367. doi:  10.1111/j.1365-2133.2006.07597.x
    [9] Bonaci-Nikolic B, Nikolic MM, Andrejevic S, et al. Antineutrophil cytoplasmic antibody (ANCA) -associated autoimmune diseases induced by antithyroid drugs:comparison with idiopathic ANCA vasculitides[J]. Arthritis Res Ther, 2005, 7:1072-1081. doi:  10.1186/ar1789
    [10] Dolman KM, Gans ROB, Vervatt TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy[J]. Lancet, 1993, 342:651-652. doi:  10.1016/0140-6736(93)91761-A
    [11] Calañas-Continente A, Espinosa M, Manzano-García G, et al. Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy[J]. Thyroid, 2005, 15:286-288. doi:  10.1089/thy.2005.15.286
    [12] Batchelor N, Holley A. A fatal case of propylthiouracil-induced ANCA-positive vasculitis[J]. MedGenMed, 2006, 8:10. http://www.ncbi.nlm.nih.gov/pubmed/17415292
    [13] Kimura S, Ikeda-Saito M. Human myeloperoxidase and thyroid peroxidase, two enzymes with separate and distinct physiological functions, are evolutionarily related members of the same gene family[J]. Proteins, 1988, 3:113-120. doi:  10.1002/prot.340030206
    [14] Jiang X, Khursigara G, Rubin RL. Transformation of lupusinducing drugs to cytotoxic products by activated neutrophils[J]. Science, 1994, 266:810-813. http://www.ncbi.nlm.nih.gov/pubmed/7973636/
    [15] Radić M, Martinović Kaliterna D, Radić J. Drug-induced vasculitis:a clinical and pathological review[J]. Neth J Med, 2012, 70:12-17. http://www.ncbi.nlm.nih.gov/pubmed/22271809
    [16] Nozato K, Morishima Y, Furuta J, et al. A case of HenochSchönlein purpura which was difficult to distinguish from a skin rash associated with gefitinib[J]. Nihon Kokyuki Gakkai Zasshi, 2010, 48:529-534. http://europepmc.org/abstract/MED/20684219
    [17] Yuba T, Nagata K, Shiotsu S, et al. Henoch-schönlein purpura induced by erlotinib (Tarceva):a case report[J]. Nihon Kokyuki Gakkai Zasshi, 2010, 48:81-85. http://www.ncbi.nlm.nih.gov/pubmed/20163028
    [18] Aktas B, Topcuoglu P, Kurt OK, et al. Severe HenochSchönlein purpura induced by cytarabine[J]. Ann Pharmacother, 2009, 43:792-793. doi:  10.1345/aph.1L608
    [19] Park SJ, Kim JH, Shin JI. Is there a link between the use of etanercept and Henoch-Schönlein purpura? Comment on:Henoch-Schonlein purpura in a patient with the rheumatoid arthritis receiving etanercept[J]. Eur J Dermatol, 2011, 21:147. doi:  10.1684/ejd.2010.1198
    [20] Pellegrini F, Rossi V, Fassone F, et al. Henoch-Schönlein purpura and aromatase inhibitors[J]. Eur J Dermatol, 2009, 19:519-520. doi:  10.1684/ejd.2009.0745
    [21] Borrás-Blasco J, Enriquez R, Amoros F, et al. HenochSchönlein purpura associated with clarithromycin. Case report and review of literature[J]. Int J Clin Pharmacol Ther, 2003, 41:213-216. doi:  10.5414/CPP41213
    [22] Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus[J]. Clin Dermatol, 1998, 16:393-397. doi:  10.1016/S0738-081X(98)00010-8
    [23] Goldberg I, Shirazi I, Brenner S. In vitro interferon-gamma release test in patients with drug-induced pemphigus[J]. Isr Med Assoc J, 2008, 10:424-427. http://www.ncbi.nlm.nih.gov/pubmed/18669138
    [24] 冯素英, 周武庆, 靳培英.药物诱发天疱疮6例分析[J].临床皮肤科杂志, 2011, 40:396-399. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lcpfkzz201107005
    [25] Tang X, Zhang X. Drug-induced pemphigus after six years of treatment with phenytoin and carbamazepine[J]. Int J Dermatol, 2012, 51:485-486. doi:  10.1111/j.1365-4632.2010.04706.x
    [26] 刘冰, 左亚刚.药物诱发大疱性类天疱疮[J].国际皮肤性病学杂志, 2012, 38:235-238. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=gwyx-pfxbx201204010
    [27] Berg D, Otley C. Skin cancer in organ transplant recipients:epidemiology, pathogenesis and management[J]. J Am Acad Dermatol, 2002, 47:1-17. doi:  10.1067/mjd.2002.125579
    [28] Tessari G, Naldi L, Boschiero L, et al. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer:a multicenter cohort study[J]. Arch Dermatol, 2010, 146:294-299. http://www.cabdirect.org/abstracts/20103124058.html
    [29] Subramaniam K, Pavli P. Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease[J]. J Gastroenterol Hepatol, 2012, 27:193-194. doi:  10.1111/j.1440-1746.2011.07030.x
    [30] O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage[J]. Science, 2005, 309:1871-1874. doi:  10.1126/science.1114233
    [31] Epaulard O, Leccia MT, Blanche S, et al. Phototoxicity and photocarcinogenesis associated with voriconazole[J]. Med Mal Infect, 2011, 41:639-645. doi:  10.1016/j.medmal.2011.09.016
    [32] McCarthy KL, Playford EG, Looke DF, et al. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy[J]. Clin Infect Dis, 2007, 44:55-56. doi:  10.1086/511685
    [33] Brunel AS, Fraisse T, Lechiche C, et al. Multifocal squamous cell carcinomas in an HIV-infected patient with a longterm voriconazole therapy[J]. AIDS, 2008, 22:905-906. doi:  10.1097/QAD.0b013e3282f706a9
    [34] Miller DD, Cowen EW, Nguyen JC, et al. Melanoma associated with long-term voriconazole therapy:a new manifestation of chronic photosensitivity[J]. Arch Dermatol, 2010, 146:300-304. http://www.cabdirect.org/abstracts/20103124059.html
    [35] Arnault JP, Mateus C, Escudier B, et al. Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1[J]. Clin Cancer Res, 2012, 18:263-272. doi:  10.1158/1078-0432.CCR-11-1344
    [36] Sanli H, Ataman S, Akay BN, et al. Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy[J]. J Drugs Dermatol, 2007, 6:834-836. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=d37135fd9f52744f716978bcb59659bf
    [37] Dommasch E, Gelfand JM. Is there truly a risk of lymphoma from biologic therapies?[J]. Dermatol Ther, 2009, 22:418-430. doi:  10.1111/j.1529-8019.2009.01258.x
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  214
  • HTML全文浏览量:  69
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-07-26
  • 刊出日期:  2012-10-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！